Home / Sweden / CellaVision AB
CellaVision AB
SE0000683484 Short position disclosed on July 30, 2026.
0.59% of the capital sold short
1 disclosing funds
12 disclosures on record
Evolution of the disclosed total
Open positions
| Fund | % of capital | Since |
|---|---|---|
| Citadel Advisors LLC | 0.59% | July 30, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 30, 2026 | Citadel Advisors LLC | 0.59% | still open |
| June 26, 2026 | Citadel Advisors LLC | 0.60% | still open |
| June 15, 2026 | Citadel Advisors LLC | 0.50% | still open |
| December 17, 2019 | Bodenholm Capital AB | 0.00% | still open |
| September 27, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | still open |
| September 2, 2019 | Bodenholm Capital AB | 0.53% | still open |
| September 1, 2019 | Bodenholm Capital AB | 0.53% | still open |
| August 15, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | still open |
| August 14, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.50% | still open |
| August 1, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.00% | still open |
| July 5, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% | still open |
| July 4, 2019 | Keel Capital S.A., Sicav-Sif – Foghorn X2 | 0.51% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.32% of the capital sold short
- Elekta AB (publ) 10.26% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 6.06% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.61% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Truecaller AB 5.38% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Aktiebolaget Electrolux 4.12% of the capital sold short
- Stillfront Group AB (publ) 3.96% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short